Edwardine Labay from Chicago, IL, age 71

Tissue-Specific Basement Membrane Gels
view source
US Patent:

20070190165, Aug 16, 2007
Filed:

Oct 23, 2006
Appl. No.:

11/585353
Inventors:

Eric Brey - Chicago IL, US
Shiri Uriel - Chicago IL, US
Edwardine Labay - Des Plaines IL, US
Ralph Weichselbaum - Chicago IL, US
International Classification:

A61K 35/12
US Classification:

424520000
Abstract:

Methods are provided for basement membrane extraction and gellation whereby a biologically active, stable, three dimensional gel can be induced within five minutes or less with basement membrane components from substantially any tissue selected by the preparer. The three dimensional gel can further be substantially free of cellular contaminants. Thus, a wide range of diagnostic and therapeutic uses for such gels can be made available.

Prognosis And Therapy Predictive Markers And Methods Of Use
view source
US Patent:

20090011439, Jan 8, 2009
Filed:

Jan 19, 2007
Appl. No.:

12/087964
Inventors:

Ralph Weichselbaum - Chicago IL, US
Bernard Roizman - Chicago IL, US
Andy Minn - Chicago IL, US
Nikolai Khodarev - Villa Park IL, US
Edwardine Labay - Des Plaines IL, US
International Classification:

G01N 33/574
US Classification:

435 723
Abstract:

Disclosed is a set of genes differentially expressed in chemotherapy and radiation resistant tumors useful in predicting response to therapy and assessing risk of local-regional failure, survival and metastasis in cancer patients. Also disclosed are methods for characterizing tumors according to gene expression and kits for use in the methods of the invention.

Prognosis And Therapy Predictive Markers And Methods Of Use
view source
US Patent:

20110200998, Aug 18, 2011
Filed:

Feb 8, 2011
Appl. No.:

13/023331
Inventors:

Ralph Weichselbaum - Chicago IL, US
Bernard Roizman - Chicago IL, US
Andy Minn - Chicago IL, US
Nikolai Khodarev - Villa Park IL, US
Edwardine Labay - Des Plaines IL, US
Assignee:

THE UNIVERSITY OF CHICAGO - Chicago IL
International Classification:

C12Q 1/68
US Classification:

435 611
Abstract:

Disclosed is a set of genes differentially expressed in chemotherapy and radiation resistant tumors useful in predicting response to therapy and assessing risk of local-regional failure, survival and metastasis in cancer patients. Also disclosed are methods for characterizing tumors according to gene expression and kits for use in the methods of the invention.

Prognosis And Therapy Predictive Markers And Methods Of Use
view source
US Patent:

20130150258, Jun 13, 2013
Filed:

Jan 4, 2013
Appl. No.:

13/734527
Inventors:

The University of Chicago - Chicago IL, US
Bernard Roizman - Chicago IL, US
Andy Minn - Chicago IL, US
Nikolai Khodarev - Villa Park IL, US
Edwardine Labay - Des Plaines IL, US
Assignee:

The University of Chicago - Chicago IL
International Classification:

C12Q 1/68
US Classification:

506 9
Abstract:

Disclosed is a set of genes differentially expressed in chemotherapy and radiation resistant tumors useful in predicting response to therapy and assessing risk of local-regional failure, survival and metastasis in cancer patients. Also disclosed are methods for characterizing tumors according to gene expression and kits for use in the methods of the invention.

Edwardine Labay